AAAAAA

   
Results: 1-11 |
Results: 11
PROPHYLAXIS AGAINST SOMAN INHALATION TOXICITY IN GUINEA-PIGS BY PRETREATMENT ALONE WITH HUMAN SERUM BUTYRYLCHOLINESTERASE
Authors: ALLON N RAVEH L GILAT E COHEN E GRUNWALD J ASHANI Y
Citation: N. Allon et al., PROPHYLAXIS AGAINST SOMAN INHALATION TOXICITY IN GUINEA-PIGS BY PRETREATMENT ALONE WITH HUMAN SERUM BUTYRYLCHOLINESTERASE, TOXICOLOGICAL SCIENCES, 43(2), 1998, pp. 121-128
ROLE OF OLIGOSACCHARIDES IN THE PHARMACOKINETICS OF TISSUE-DERIVED AND GENETICALLY-ENGINEERED CHOLINESTERASES
Authors: SAXENA A ASHANI Y RAVEH L STEVENSON D PATEL T DOCTOR BP
Citation: A. Saxena et al., ROLE OF OLIGOSACCHARIDES IN THE PHARMACOKINETICS OF TISSUE-DERIVED AND GENETICALLY-ENGINEERED CHOLINESTERASES, Molecular pharmacology, 53(1), 1998, pp. 112-122
FUNCTIONAL-CHARACTERIZATION OF GLYCAN STRUCTURES IN CHOLINESTERASES
Authors: SAXENA A ASHANI Y RAVEH L DOCTOR BP
Citation: A. Saxena et al., FUNCTIONAL-CHARACTERIZATION OF GLYCAN STRUCTURES IN CHOLINESTERASES, The FASEB journal, 11(9), 1997, pp. 2289-2289
LARGE-SCALE PURIFICATION AND LONG-TERM STABILITY OF HUMAN BUTYRYLCHOLINESTERASE - A POTENTIAL BIOSCAVENGER DRUG
Authors: GRUNWALD J MARCUS D PAPIER Y RAVEH L PITTEL Z ASHANI Y
Citation: J. Grunwald et al., LARGE-SCALE PURIFICATION AND LONG-TERM STABILITY OF HUMAN BUTYRYLCHOLINESTERASE - A POTENTIAL BIOSCAVENGER DRUG, Journal of biochemical and biophysical methods, 34(2), 1997, pp. 123-135
THE STOICHIOMETRY OF PROTECTION AGAINST SOMAN AND VX TOXICITY IN MONKEYS PRETREATED WITH HUMAN BUTYRYLCHOLINESTERASE
Authors: RAVEH L GRAUER E GRUNWALD J COHEN E ASHANI Y
Citation: L. Raveh et al., THE STOICHIOMETRY OF PROTECTION AGAINST SOMAN AND VX TOXICITY IN MONKEYS PRETREATED WITH HUMAN BUTYRYLCHOLINESTERASE, Toxicology and applied pharmacology, 145(1), 1997, pp. 43-53
STRUCTURE OF GLYCAN MOIETIES RESPONSIBLE FOR THE EXTENDED CIRCULATORYLIFE TIME OF FETAL BOVINE SERUM ACETYLCHOLINESTERASE AND EQUINE SERUMBUTYRYLCHOLINESTERASE
Authors: SAXENA A RAVEH L ASHANI Y DOCTOR BP
Citation: A. Saxena et al., STRUCTURE OF GLYCAN MOIETIES RESPONSIBLE FOR THE EXTENDED CIRCULATORYLIFE TIME OF FETAL BOVINE SERUM ACETYLCHOLINESTERASE AND EQUINE SERUMBUTYRYLCHOLINESTERASE, Biochemistry, 36(24), 1997, pp. 7481-7489
SARIN-INDUCED NEUROPATHOLOGY IN RATS
Authors: KADAR T SHAPIRA S COHEN G SAHAR R ALKALAY D RAVEH L
Citation: T. Kadar et al., SARIN-INDUCED NEUROPATHOLOGY IN RATS, Human & experimental toxicology, 14(3), 1995, pp. 252-259
HUPERZINE A AS A PRETREATMENT CANDIDATE DRUG AGAINST NERVE AGENT TOXICITY
Authors: GRUNWALD J RAVEH L DOCTOR BP ASHANI Y
Citation: J. Grunwald et al., HUPERZINE A AS A PRETREATMENT CANDIDATE DRUG AGAINST NERVE AGENT TOXICITY, Life sciences, 54(14), 1994, pp. 991-997
AMPLIFICATION OF THE EFFECTIVENESS OF ACETYLCHOLINESTERASE FOR DETOXIFICATION OF ORGANOPHOSPHORUS COMPOUNDS BY BIS-QUATERNARY OXIMES
Authors: CARANTO GR WAIBEL KH ASHER JM LARRISON RW BRECHT KM SCHUTZ MB RAVEH L ASHANI Y WOLFE AD MAXWELL DM DOCTOR BP
Citation: Gr. Caranto et al., AMPLIFICATION OF THE EFFECTIVENESS OF ACETYLCHOLINESTERASE FOR DETOXIFICATION OF ORGANOPHOSPHORUS COMPOUNDS BY BIS-QUATERNARY OXIMES, Biochemical pharmacology, 47(2), 1994, pp. 347-357
PREVENTION OF SOMAN-INDUCED COGNITIVE DEFICITS BY PRETREATMENT WITH HUMAN BUTYRYLCHOLINESTERASE IN RATS
Authors: BRANDEIS R RAVEH L GRUNWALD J COHEN E ASHANI Y
Citation: R. Brandeis et al., PREVENTION OF SOMAN-INDUCED COGNITIVE DEFICITS BY PRETREATMENT WITH HUMAN BUTYRYLCHOLINESTERASE IN RATS, Pharmacology, biochemistry and behavior, 46(4), 1993, pp. 889-896
HUMAN BUTYRYLCHOLINESTERASE AS A GENERAL PROPHYLACTIC ANTIDOTE FOR NERVE AGENT TOXICITY - INTRO AND IN-VIVO QUANTITATIVE CHARACTERIZATION
Authors: RAVEH L GRUNWALD J MARCUS D PAPIER Y COHEN E ASHANI Y
Citation: L. Raveh et al., HUMAN BUTYRYLCHOLINESTERASE AS A GENERAL PROPHYLACTIC ANTIDOTE FOR NERVE AGENT TOXICITY - INTRO AND IN-VIVO QUANTITATIVE CHARACTERIZATION, Biochemical pharmacology, 45(12), 1993, pp. 2465-2474
Risultati: 1-11 |